Creutzfeldt-Jakob disease and mad cows: Lessons learnt from yeast cells

Swiss Medical Weekly

Volumn 142, Issue 1, 2012, Pages

  Hofmann, Julia ^a   Wolf, Hanna ^a   Grassmann, Andrea ^a   Arndt, Verena ^a   Graham, James ^a   Vorberg, Ina ^a,b  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

BSE; Creutzfeldt Jakob; Neurodegeneration; Prion; Transmissible spongiform encephalopathy

Indexed keywords

AMYLOID; CHAPERONE; PRION PROTEIN;

BIOGENESIS; CREUTZFELDT JAKOB DISEASE; EPIGENETICS; NONHUMAN; PRION; PROTEIN AGGREGATION; REVIEW; VIRION; YEAST CELL; ANIMAL; BIOLOGICAL MODEL; BOVINE SPONGIFORM ENCEPHALOPATHY; CATTLE; CYTOLOGY; DISEASE TRANSMISSION; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; PATHOGENICITY; YEAST;

ANIMALS; CATTLE; CREUTZFELDT-JAKOB SYNDROME; ENCEPHALOPATHY, BOVINE SPONGIFORM; HUMANS; MODELS, BIOLOGICAL; PRIONS; YEASTS;

EID: 84856789967     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2012.13505     Document Type: Review

References (82)

1. Aguzzi A. Prion diseases of humans and farm animals: Epidemiology, genetics, and pathogenesis. J Neurochem. 2006;97(6):1726-39. (Pubitemid 43873663)
2. McGowan J. Scrapie in sheep. Scott J Agric. 1922;5:365-75.
3. Sigurdson CJ, Miller MW. Other animal prion diseases. Br Med Bull. 2003;66:199-212. (Pubitemid 37173503)
4. Wadsworth JD, Collinge J. Molecular pathology of human prion disease. Acta Neuropathol. 2011;121(1):69-77.
5. Mead S. Prion disease genetics. Eur J Hum Genet. 2006;14(3):273-81.
6. Norrby E. Prions and protein-folding diseases. J Intern Med. 2011;270(1):1-14.
7. Alpers MP. Review. The epidemiology of kuru: Monitoring the epidemic from its peak to its end. Philos Trans R Soc Lond B Biol Sci. 2008;363(1510):3707- 13.
8. Collinge J. Variant creutzfeldt-jakob disease. Lancet. 1999;354(9175):317-23. (Pubitemid 29348751)
9. Anderson RM, Donnelly CA, Ferguson NM, Woolhouse ME, Watt CJ, Udy HJ, et al. Transmission dynamics and epidemiology of bse in british cattle. Nature. 1996;382(6594):779-88. (Pubitemid 26299555)
10. Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, et al. The same prion strain causes vcjd and bse. Nature. 1997;389(6650):448-50, 526.
11. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vcjd after blood transfusion in a prnp codon 129 heterozygous patient. Lancet. 2004;364(9433):527-9. (Pubitemid 39070413)
12. Griffith JS. Self-replication and scrapie. Nature. 1967;215(5105):1043-4.
13. Bolton DC, McKinley MP, Prusiner SB. Identification of a protein that purifies with the scrapie prion. Science. 1982;218(4579):1309-11.
14. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216(4542):136-44. (Pubitemid 12089840)
15. Goedert M, Clavaguera F, Tolnay M. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci. 2010;33(7):317-25.
16. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, et al. The most infectious prion protein particles. Nature. 2005;437(7056):257-61. (Pubitemid 41294488)
17. Stahl N, Borchelt DR, Hsiao K, Prusiner SB. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell. 1987;51(2):229-40.
18. Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol. Review. 2088;88:673-728.
19. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, et al. Mice devoid of prp are resistant to scrapie. Cell. 1993;73(7):1339-47. (Pubitemid 23201147)
20. Wong BS, Liu T, Li R, Pan T, Petersen RB, Smith MA, et al. Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J Neurochem. 2001;76(2):565-72. (Pubitemid 32097032)
21. Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev. 2008;88(2):673-728. (Pubitemid 351520090)
22. Bremer J, Baumann F, Tiberi C, Wessig C, Fischer H, Schwarz P, et al. Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci. 2010;13(3):310-8.
23. Stahl N, Baldwin MA, Teplow DB, Hood L, Gibson BW, Burlingame AL, et al. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry. 1993;32(8):1991-2002. (Pubitemid 23086050)
24. Gasset M, Baldwin MA, Fletterick RJ, Prusiner SB. Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc Natl Acad Sci U S A. 1993;90(1):1-5. (Pubitemid 23010237)
25. Borchelt DR, Taraboulos A, Prusiner SB. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J Biol Chem. 1992;267(23):16188-99.
26. Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner SB. Cholesterol depletion and modification of cooh-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol. 1995;129(1):121-32.
27. Marijanovic Z, Caputo A, Campana V, Zurzolo C. Identification of an intracellular site of prion conversion. PLoS Pathog. 2009;5(5):e1000426
28. Horiuchi M, Priola SA, Chabry J, Caughey B. Interactions between heterologous forms of prion protein: Binding, inhibition of conversion, and species barriers. Proc Natl Acad Sci U S A. 2000;97(11):5836-41. (Pubitemid 30367485)
29. Wadsworth JD, Asante EA, Desbruslais M, Linehan JM, Joiner S, Gowland I, et al. Human prion protein with valine 129 prevents expression of variant cjd phenotype. Science. 2004;306(5702):1793-6. (Pubitemid 39601400)
30. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science. 1996;274(5295):2079-82. (Pubitemid 27020700)
31. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, et al. Eight prion strains have prp(sc) molecules with different conformations. Nat Med. 1998;4(10):1157-65. (Pubitemid 28468829)
32. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT, Caughey B. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature. 1995;375(6533):698-700.
33. Manuelidis L, Yu ZX, Barquero N, Mullins B. Cells infected with scrapie and creutzfeldt-jakob disease agents produce intracellular 25-nm virus-like particles. Proc Natl Acad Sci U S A. 2007;104(6):1965-70. (Pubitemid 46239887)
34. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature. 2001;411(6839):810-3. (Pubitemid 32588105)
35. Castilla J, Saa P, Hetz C, Soto C. In vitro generation of infectious scrapie prions. Cell. 2005;121(2):195-206. (Pubitemid 40546388)
36. Soto C, Saborio GP, Anderes L. Cyclic amplification of protein misfolding: Application to prion-related disorders and beyond. Trends Neurosci. 2002;25(8):390-4. (Pubitemid 34804458)
37. Deleault NR, Geoghegan JC, Nishina K, Kascsak R, Williamson RA, Supattapone S. Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions. J Biol Chem. 2005;280(29):26873-9. (Pubitemid 41040721)
38. Wong C, Xiong LW, Horiuchi M, Raymond L, Wehrly K, Chesebro B, et al. Sulfated glycans and elevated temperature stimulate prp(sc)-dependent cell-free formation of protease-resistant prion protein. EMBO J. 2001;20(3):377-86. (Pubitemid 32126974)
39. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, et al. Synthetic mammalian prions. Science. 2004;305(5684):673-6. (Pubitemid 39006757)
40. Makarava N, Kovacs GG, Bocharova O, Savtchenko R, Alexeeva I, Budka H, et al. Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol. 2010;119(2):177-87.
41. Wang F, Wang X, Yuan CG, Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science. 2010;327(5969):1132-5.
42. Baskakov IV. The reconstitution of mammalian prion infectivity de novo. FEBS J. 2007;274(3):576-87. (Pubitemid 46144025)
43. Wickner RB. [ure3] as an altered ure2 protein: Evidence for a prion analog in saccharomyces cerevisiae. Science. 1994;264(5158):566-9. (Pubitemid 24185861)
44. Aigle M, Lacroute F. Genetical aspects of [ure3], a non-mitochondrial, cytoplasmically inherited mutation in yeast. Mol Gen Genet. 1975;136(4):327-35.
45. Patino MM, Liu JJ, Glover JR, Lindquist S. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science. 1996;273(5275):622-6. (Pubitemid 26262109)
46. Halfmann R, Lindquist S. Epigenetics in the extreme: Prions and the inheritance of environmentally acquired traits. Science. 2010;330(6004):629-32.
47. Wickner RB, Edskes HK, Bateman D, Kelly AC, Gorkovskiy A. The yeast prions [psi+] and [ure3] are molecular degenerative diseases. Prion. 2011;5(4):
48. Wickner RB, Edskes HK, Shewmaker F, Nakayashiki T, Engel A, McCann L, et al. Yeast prions: Evolution of the prion concept. Prion. 2007;1(2):94-100.
49. Uptain SM, Lindquist S. Prions as protein-based genetic elements. Annu Rev Microbiol. 2002;56:703-41. (Pubitemid 35217472)
50. Coustou V, Deleu C, Saupe S, Begueret J. The protein product of the het-s heterokaryon incompatibility gene of the fungus podospora anserina behaves as a prion analog. Proc Natl Acad Sci U S A. 1997;94(18):9773-8. (Pubitemid 27408139)
51. Ross ED, Edskes HK, Terry MJ, Wickner RB. Primary sequence independence for prion formation. Proc Natl Acad Sci U S A. 2005;102(36):12825-30. (Pubitemid 41279450)
52. Schlumpberger M, Prusiner SB, Herskowitz I. Induction of distinct [ure3] yeast prion strains. Mol Cell Biol. 2001;21(20):7035-46. (Pubitemid 32911263)
53. Tanaka M, Chien P, Naber N, Cooke R, Weissman JS. Conformational variations in an infectious protein determine prion strain differences. Nature. 2004;428(6980):323-8. (Pubitemid 38418803)
54. Sparrer HE, Santoso A, Szoka FC, Jr., Weissman JS. Evidence for the prion hypothesis: Induction of the yeast [psi+] factor by in vitro- converted sup35 protein. Science. 2000;289(5479):595-9. (Pubitemid 30622057)
55. Brachmann A, Baxa U, Wickner RB. Prion generation in vitro: Amyloid of ure2p is infectious. EMBO J. 2005;24(17):3082-92. (Pubitemid 41486344)
56. Chien P, Weissman JS, DePace AH. Emerging principles of conformation-based prion inheritance. Annu Rev Biochem. 2004;73:617-56. (Pubitemid 39050382)
57. King CY, Diaz-Avalos R. Protein-only transmission of three yeast prion strains. Nature. 2004;428(6980):319-23. (Pubitemid 38418802)
58. Derkatch IL, Bradley ME, Zhou P, Chernoff YO, Liebman SW. Genetic and environmental factors affecting the de novo appearance of the [psi+] prion in saccharomyces cerevisiae. Genetics. 1997;147(2):507-19. (Pubitemid 27418562)
59. Scherzinger E, Sittler A, Schweiger K, Heiser V, Lurz R, Hasenbank R, et al. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for huntington's disease pathology. Proc Natl Acad Sci U S A. 1999;96(8):4604-9. (Pubitemid 29190383)
60. Derkatch IL, Uptain SM, Outeiro TF, Krishnan R, Lindquist SL, Liebman SW. Effects of q/n-rich, polyq, and non-polyq amyloids on the de novo formation of the [psi+] prion in yeast and aggregation of sup35 in vitro. Proc Natl Acad Sci U S A. 2004;101(35):12934-9. (Pubitemid 39167561)
61. Derkatch IL, Bradley ME, Hong JY, Liebman SW. Prions affect the appearance of other prions: The story of [pin(+)]. Cell. 2001;106(2):171-82. (Pubitemid 32772628)
62. Sweeny EA, Shorter J. Prion proteostasis: Hsp104 meets its supporting cast. Prion. 2008;2(4):135-40.
63. Shorter J, Lindquist S. Hsp104, hsp70 and hsp40 interplay regulates formation, growth and elimination of sup35 prions. EMBO J. 2008;27(20):2712-24.
64. Wegrzyn RD, Bapat K, Newnam GP, Zink AD, Chernoff YQ. Mechanism of prion loss after Hsp104 inactivation in yeast. Mol Cell Biol. 2001;14:4656-69. (Pubitemid 32588248)
65. Allen KD, Chernova TA, Tennant EP, Wilkinson KD, Chernoff YO. Effects of ubiquitin system alterations on the formation and loss of a yeast prion. J Biol Chem. 2007;282(5):3004-13. (Pubitemid 47084312)
66. Tyedmers J, Madariaga ML, Lindquist S. Prion switching in response to environmental stress. PLoS Biol. 2008;6(11):e294
67. Chernova TA, Romanyuk AV, Karpova TS, Shanks JR, Ali M, Moffatt N, et al. Prion induction by the short-lived, stress-induced protein lsb2 is regulated by ubiquitination and association with the actin cytoskeleton. Mol Cell. 2011;43(2):242-52.
68. Ganusova EE, Ozolins LN, Bhagat S, Newnam GP, Wegrzyn RD, Sherman MY, et al. Modulation of prion formation, aggregation, and toxicity by the actin cytoskeleton in yeast. Mol Cell Biol. 2006;26(2):617-29. (Pubitemid 43089773)
69. Redeker V, Hughes C, Savistchenko J, Vissers JP, Melki R. Qualitative and quantitative multiplexed proteomic analysis of complex yeast protein fractions that modulate the assembly of the yeast prion sup35p. PLoS One. 2011;6(9):e23659.
70. Fowler DM, Koulov AV, Balch WE, Kelly JW. Functional amyloid - from bacteria to humans. Trends Biochem Sci. 2007;32(5):217-24. (Pubitemid 46694328)
71. Badtke MP, Hammer ND, Chapman MR. Functional amyloids signal their arrival. Sci Signal. 2009;2(80):pe43.
72. Iconomidou VA, Chryssikos GD, Gionis V, Galanis AS, Cordopatis P, Hoenger A, et al. Amyloid fibril formation propensity is inherent into the hexapeptide tandemly repeating sequence of the central domain of silkmoth chorion proteins of the a-family. J Struct Biol. 2006;156(3):480-8. (Pubitemid 44751479)
73. Kenney JM, Knight D, Wise MJ, Vollrath F. Amyloidogenic nature of spider silk. Eur J Biochem. 2002;269(16):4159-63. (Pubitemid 34994911)
74. Si K, Choi YB, White-Grindley E, Majumdar A, Kandel ER. Aplysia cpeb can form prion-like multimers in sensory neurons that contribute to long-term facilitation. Cell. 2010;140(3):421-35.
75. Fowler DM, Koulov AV, Alory-Jost C, Marks MS, Balch WE, Kelly JW. Functional amyloid formation within mammalian tissue. PLoS Biol. 2006;4(1):e6.
76. Maji SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, Rissman RA, et al. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science. 2009;325(5938):328-32.
77. Maddelein ML, Dos Reis S, Duvezin-Caubet S, Coulary-Salin B, Saupe SJ. Amyloid aggregates of the het-s prion protein are infectious. Proc Natl Acad Sci U S A. 2002;99(11):7402-7. (Pubitemid 34568703)
78. Alberti S, Halfmann R, King O, Kapila A, Lindquist S. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell. 2009;137(1):146-58.
79. Hou F, Sun L, Zheng H, Skaug B, Jiang QX, Chen ZJ. Mavs forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell. 2011;146(3):448-61.
80. Aguzzi A. Cell biology: Beyond the prion principle. Nature. 2009;459(7249):924-5.
81. Krammer C, Kryndushkin D, Suhre MH, Kremmer E, Hofmann A, Pfeifer A, et al. The yeast sup35nm domain propagates as a prion in mammalian cells. Proc Natl Acad Sci U S A. 2009;106(2):462-7.
82. Aguzzi A, Rajendran L. The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron. 2009;64(6):783-90.